Vascular calcification and ESRD: a hard target
- PMID: 19995990
- DOI: 10.2215/CJN.04800709
Vascular calcification and ESRD: a hard target
Abstract
End-stage renal disease (ESRD) is associated with both accelerated cardiovascular disease and alterations in vitamin D and mineral metabolism. Calcification of both coronary and extra-cardiac vessels is common in ESRD. Several studies suggest that vascular calcification is associated with coronary atherosclerosis, vascular wall stiffness, left ventricular hypertrophy, and subsequent increased mortality, but it is not yet clear if vascular calcification is a direct cause of these changes or merely a marker of disease. Reviewed here is the current state of research on the biology and the significance of vascular calcification in ESRD, the role of vitamin D therapy in its development, and options for management.
Similar articles
-
Vascular calcification and disordered mineral metabolism in dialysis patients.Semin Dial. 2007 Mar-Apr;20(2):139-43. doi: 10.1111/j.1525-139X.2007.00261.x. Semin Dial. 2007. PMID: 17374088 Review.
-
Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.J Ren Nutr. 2006 Apr;16(2):100-18. doi: 10.1053/j.jrn.2006.01.006. J Ren Nutr. 2006. PMID: 16567266 Review.
-
[Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].G Ital Nefrol. 2007 Sep-Oct;24 Suppl 38:25-32. G Ital Nefrol. 2007. PMID: 17922444 Italian.
-
[Vitamin D, cardiovascular disease and mortality in patients with kidney disease].Ugeskr Laeger. 2009 Dec 7;171(50):3684-9. Ugeskr Laeger. 2009. PMID: 20003863 Review. Danish.
-
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.Nephrol Dial Transplant. 2006 Jul;21(7):1906-14. doi: 10.1093/ndt/gfl098. Epub 2006 Mar 22. Nephrol Dial Transplant. 2006. PMID: 16554325
Cited by
-
Clinical, patient-related, and economic outcomes of home-based high-dose hemodialysis versus conventional in-center hemodialysis.Int J Nephrol Renovasc Dis. 2016 Jul 5;9:151-9. doi: 10.2147/IJNRD.S89411. eCollection 2016. Int J Nephrol Renovasc Dis. 2016. PMID: 27462173 Free PMC article. Review.
-
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis.Int Urol Nephrol. 2015 Mar;47(3):527-35. doi: 10.1007/s11255-014-0876-x. Epub 2014 Nov 16. Int Urol Nephrol. 2015. PMID: 25399356
-
Effect of low-dose lanthanum carbonate on calcium and phosphorus metabolism in Asian Patients with end-stage renal disease, maintenance hemodialysis and hyperphosphatemia.Afr Health Sci. 2022 Jun;22(2):362-368. doi: 10.4314/ahs.v22i2.41. Afr Health Sci. 2022. PMID: 36407374 Free PMC article.
-
Abdominal aorta calcification predicts cardiovascular but not non-cardiovascular outcome in patients receiving peritoneal dialysis: A prospective cohort study.Medicine (Baltimore). 2020 Sep 11;99(37):e21730. doi: 10.1097/MD.0000000000021730. Medicine (Baltimore). 2020. PMID: 32925715 Free PMC article.
-
Association of serum phosphorus variability with coronary artery calcification among hemodialysis patients.PLoS One. 2014 Apr 18;9(4):e93360. doi: 10.1371/journal.pone.0093360. eCollection 2014. PLoS One. 2014. PMID: 24747427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical